ArticleBMC nephrology2025
Association between the triglyceride to high-density lipoprotein cholesterol ratio and diabetes mellitus likelihood in patients with chronic kidney disease.
Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cumulative of c-reactive protein-triglyceride glucose index exposure and risk of diabetes in middle-aged and older Chinese adults: findings from a national longitudinal cohort.Diabetology & metabolic syndrome · 2025Article
- Predictive Value of Triglyceride/HDL-C Ratio for Unplanned Coronary Revascularization in Elderly Patients With Type 2 Diabetes and Coronary Artery Disease: A Retrospective Cohort Study.Aging medicine (Milton (N.S.W)) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPatients with chronic kidney disease (CKD) are at an increased risk of diabetes mellitus (DM) and dyslipidemia, yet the specific relationship between lipid profiles, particularly triglyceride-to-high-density lipoprotein cholesterol ratio (TG/HDL-C ratio), and DM likelihood in this population has not been thoroughly elucidated.
methodsWe conducted a cross-sectional analysis of 20,310 unselected patients with CKD enrolled from 2006 to 2015. The relationship between the TG/HDL-C ratio and the likelihood of DM was evaluated using binary logistic regression. Sensitivity and subgroup analyses were performed, and a generalized additive model with smooth curve fitting assessed potential non-linear associations. We also performed the receiver operating characteristic (ROC) curve and decision curve analysis to assess the determination and clinical use, respectively.
resultsAmong the participants (mean age 60.907 ± 10.044 years; 79.580% male), 1,758 (8.656%) had DM. The median TG/HDL-C ratio was 0.655(interquartile range 0.465-0.920). After adjusting for covariates, a significant positive association was found between the TG/HDL-C ratio and DM likelihood (odds ratio [OR], 1.494; 95% confidence interval [CI], 1.354-1.648; P < 0.001). A non-linear relationship was observed with an inflection point at a TG/HDL-C ratio of 1.030. The ORs below and above this point were 1.866 (95% CI, 1.472-2.365) and 1.297 (95% CI, 1.094-1.538), respectively. The area under curve (AUC) of the nomogram was of 0.580 (95% CI, 0.566-0.594). Subgroup analyses indicated a stronger association in patients without hypertension, in female and patients with AF.
conclusionThe TG/HDL-C ratio is independently associated with DM likelihood in patients with CKD, exhibiting a non-linear relationship particularly significant when the ratio is below 1.030. The TG/HDL-C ratio may serve as a useful marker for DM likelihood assessment in CKD patients, though prospective studies are needed to determine its role in prevention strategies. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.